Compare ALEMBIC PHARMA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ALKEM LABORATORIES ALEMBIC PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 16.4 24.4 67.2% View Chart
P/BV x 6.5 5.9 110.8% View Chart
Dividend Yield % 0.6 0.8 71.0%  

Financials

 ALEMBIC PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
ALKEM LABORATORIES
Mar-20
ALEMBIC PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs6642,720 24.4%   
Low Rs4121,660 24.8%   
Sales per share (Unadj.) Rs208.7697.9 29.9%  
Earnings per share (Unadj.) Rs31.096.1 32.2%  
Cash flow per share (Unadj.) Rs37.1117.3 31.6%  
Dividends per share (Unadj.) Rs5.5025.00 22.0%  
Dividend yield (eoy) %1.01.1 89.5%  
Book value per share (Unadj.) Rs144.2515.2 28.0%  
Shares outstanding (eoy) m188.52119.57 157.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.63.1 82.2%   
Avg P/E ratio x17.422.8 76.2%  
P/CF ratio (eoy) x14.518.7 77.6%  
Price / Book Value ratio x3.74.3 87.8%  
Dividend payout %17.726.0 68.2%   
Avg Mkt Cap Rs m101,461261,879 38.7%   
No. of employees `000NA14.3 0.0%   
Total wages/salary Rs m7,46715,055 49.6%   
Avg. sales/employee Rs ThNM5,822.6-  
Avg. wages/employee Rs ThNM1,050.5-  
Avg. net profit/employee Rs ThNM802.0-  
INCOME DATA
Net Sales Rs m39,34783,444 47.2%  
Other income Rs m941,042 9.0%   
Total revenues Rs m39,44184,486 46.7%   
Gross profit Rs m8,73614,734 59.3%  
Depreciation Rs m1,1522,528 45.6%   
Interest Rs m184651 28.3%   
Profit before tax Rs m7,49312,598 59.5%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5681,105 141.9%   
Profit after tax Rs m5,84411,493 50.8%  
Gross profit margin %22.217.7 125.7%  
Effective tax rate %20.98.8 238.5%   
Net profit margin %14.913.8 107.8%  
BALANCE SHEET DATA
Current assets Rs m19,57754,960 35.6%   
Current liabilities Rs m14,89632,433 45.9%   
Net working cap to sales %11.927.0 44.1%  
Current ratio x1.31.7 77.6%  
Inventory Days Days9080 112.8%  
Debtors Days Days4572 62.9%  
Net fixed assets Rs m27,09732,710 82.8%   
Share capital Rs m377239 157.7%   
"Free" reserves Rs m26,81161,368 43.7%   
Net worth Rs m27,18861,607 44.1%   
Long term debt Rs m4,9931,592 313.6%   
Total assets Rs m47,77899,433 48.0%  
Interest coverage x41.720.4 204.8%   
Debt to equity ratio x0.20 710.5%  
Sales to assets ratio x0.80.8 98.1%   
Return on assets %12.612.2 103.3%  
Return on equity %21.518.7 115.2%  
Return on capital %23.621.0 112.6%  
Exports to sales %019.1 0.0%   
Imports to sales %03.0 0.0%   
Exports (fob) Rs mNA15,917 0.0%   
Imports (cif) Rs mNA2,483 0.0%   
Fx inflow Rs m19,45316,061 121.1%   
Fx outflow Rs m6,0652,483 244.3%   
Net fx Rs m13,38813,578 98.6%   
CASH FLOW
From Operations Rs m8,1205,851 138.8%  
From Investments Rs m-7,556-7,414 101.9%  
From Financial Activity Rs m590792 74.6%  
Net Cashflow Rs m1,153-731 -157.7%  

Share Holding

Indian Promoters % 74.1 66.9 110.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 33.1 8.8%  
FIIs % 9.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 0.0 -  
Shareholders   49,328 68,381 72.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   FULFORD INDIA  VENUS REMEDIES  CIPLA  WOCKHARDT  AUROBINDO PHARMA  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 22, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - AUROBINDO PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS